SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-063107
Filing Date
2024-05-17
Accepted
2024-05-17 17:29:05
Documents
13
Period of Report
2024-05-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414855d1_8k.htm   iXBRL 8-K 56758
  Complete submission text file 0001104659-24-063107.txt   240180

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inhibrx-20240517.xsd EX-101.SCH 3051
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inhibrx-20240517_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inhibrx-20240517_pre.xml EX-101.PRE 22380
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2414855d1_8k_htm.xml XML 3685
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39452 | Film No.: 24961460
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)